Skip to main content

SBI Securities Co., Ltd.

SEC CIK
0001851815
Latest filing
Jul 22, 2026

BTAIQ holding history

BioXcel Therapeutics, Inc. in every 13F filed by SBI Securities Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BTAIQ overviewAll 13F holders of BTAIQFull Q2 2026 holdings

Shares (Q2 2026)
13
Value
$18
% of portfolio
<0.1%
Quarters held
7
Since Q4 2024
Holdings of BTAIQ by SBI Securities Co., Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613$18<0.1%−1−7.1%ReducedHolders
Q1 202614$19<0.1%−155−91.7%ReducedHolders
Q4 2025169$270<0.1%00.0%UnchangedHolders
Q3 2025169$433<0.1%−710−80.8%ReducedHolders
Q2 2025879$1.59K<0.1%+28+3.3%AddedHolders
Q1 2025851$1.73K<0.1%+57+7.2%AddedConverted for a 1-for-16 splitHolders
Q4 202412,701$4.75K<0.1%–No prior filingHolders